/filters:format(webp)/production/10725599/large-1765106854.png?1765106854)
focafoca99
$APYX released new clinical data on Renuvion helium plasma technology in Plastic and Reconstructive Surgery-Global Open.
APYX Apyx Medical Corp
$2.65
$0.23
(9.75%)
Closed $2.59
$0.06
(2.32%)
After Hours
EarningsNov 5
Mkt Cap$109.1M
Vol107,411.00
About APYX
Apyx Medical Corp. operates as an energy-based medical technology company. The firm engages in developing, manufacturing, and marketing a range of electrosurgical products and technologies, as well as related medical products used by the offices of doctors, surgery centers, and hospitals worldwide. It operates through the following segments: Surgical Aesthetics and Original Equipment Manufacturer (OEM). The Surgical Aesthetics segment consists of the Helium Plasma Technology lines, which include Renuvion and J-Plasma. The OEM segment focuses on designing, development, and manufacturing electrosurgical equipment and medical devices by producing generators, medical devices and related accessories. The company was founded by Andrew Makrides in 1978 and is headquartered in Clearwater, FL.
Fundamentals
52
Neutral Sentiment
How do you feel about APYX?
/filters:format(webp)/production/9852471/large-1739314458.png?1739314458)
Prof_Gulliver
$APYX I don't think the CEO can survive much longer. His track record has been abysmal, and it appears he's facing higher costs and less revenue than anticipated in the third quarter. I don't think he makes it to the end of the year.
Advertisement|Remove ads.
StocktwitsPolls12
49StocktwitsPolls117
115StocktwitsPolls38
108Advertisement|Remove ads.